Skip to main content
Top
Published in: AIDS and Behavior 4/2014

01-04-2014 | Editorial Review

Setting the Bar High or Setting Up to Fail? Interpretations and Implications of The EXPLORE Study (HPTN 015)

Authors: Seth C. Kalichman, Larissa Zohren, Lisa A. Eaton

Published in: AIDS and Behavior | Issue 4/2014

Login to get access

Abstract

Controlled studies show that HIV risk reduction counseling significantly increases condom use, reduces unprotected sex and prevents sexually transmitted infections. Nevertheless, without evidence of reducing HIV incidence, these interventions are generally discarded. One trial, the EXPLORE study, was designed to test whether ten sessions of risk reduction counseling could impact HIV incidence among men who have sex with men in six US cities. Based on epidemiologic models to define effective HIV vaccines, a 35 % reduction in HIV incidence was set a priori as the benchmark of success in this behavioral intervention trial. Results demonstrated a significant effect of the intervention, with more than a 35 % reduction in HIV incidence observed during the initial 12–18 months following counseling. Over an unprecedented 48-month follow-up, however, the effect of counseling on HIV incidence declined to 18 %. The current review examined how the scientific literature has thus far judged the outcomes of the EXPLORE study as well as the policy implications of these judgments. We identified 127 articles that cited the EXPLORE study since its publication. Among articles that discuss the HIV incidence outcomes, 20 % judged the intervention effective and 80 % judged the intervention ineffective. The overwhelmingly negative interpretation of the EXPLORE study outcomes is reflected in public policies and prevention planning. We conclude that using a vaccine standard to define success led to a broad discrediting of the benefits of behavioral counseling and, ultimately, adversely impacted policies critical to the field of HIV prevention.
Literature
1.
go back to reference Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643–56.PubMedCrossRef Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643–56.PubMedCrossRef
3.
go back to reference Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.PubMedCentralPubMedCrossRef Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.PubMedCentralPubMedCrossRef
4.
go back to reference Kelly JA, St. Lawrence JS, Hood HV, Brasfield TL. Behavioral intervention to reduce AIDS risk activities. J Consult Clin Psychol. 1989;57:60–7.PubMedCrossRef Kelly JA, St. Lawrence JS, Hood HV, Brasfield TL. Behavioral intervention to reduce AIDS risk activities. J Consult Clin Psychol. 1989;57:60–7.PubMedCrossRef
5.
go back to reference Valdiserri RO, Lyter DW, Leviton LC, Callahan CM, Kingsley LA, Rinaldo CR. AIDS prevention in homosexual and bisexual men: results of a randomized trial evaluating two risk reduction interventions. AIDS. 1989;3(1):21–6.PubMedCrossRef Valdiserri RO, Lyter DW, Leviton LC, Callahan CM, Kingsley LA, Rinaldo CR. AIDS prevention in homosexual and bisexual men: results of a randomized trial evaluating two risk reduction interventions. AIDS. 1989;3(1):21–6.PubMedCrossRef
6.
go back to reference Noar SM. Behavioral interventions to reduce HIV-related sexual risk behavior: review and synthesis of meta-analytic evidence. AIDS Behav. 2008;12(3):335–53.PubMedCrossRef Noar SM. Behavioral interventions to reduce HIV-related sexual risk behavior: review and synthesis of meta-analytic evidence. AIDS Behav. 2008;12(3):335–53.PubMedCrossRef
7.
go back to reference Johnson BT, Carey MP, Marsh KL, Levin KD, Scott-Sheldon LA. Interventions to reduce sexual risk for the human immunodeficiency virus in adolescents, 1985–2000: a research synthesis. Arch Pediatr Adolesc Med. 2003;157(4):381–8.PubMedCrossRef Johnson BT, Carey MP, Marsh KL, Levin KD, Scott-Sheldon LA. Interventions to reduce sexual risk for the human immunodeficiency virus in adolescents, 1985–2000: a research synthesis. Arch Pediatr Adolesc Med. 2003;157(4):381–8.PubMedCrossRef
8.
go back to reference Johnson BT, Scott-Sheldon LA, Smoak ND, Lacroix JM, Anderson JR, Carey MP. Behavioral interventions for African Americans to reduce sexual risk of HIV: a meta-analysis of randomized controlled trials. J Acquir Immune Defic Syndr. 2009;51(4):492–501.PubMedCentralPubMedCrossRef Johnson BT, Scott-Sheldon LA, Smoak ND, Lacroix JM, Anderson JR, Carey MP. Behavioral interventions for African Americans to reduce sexual risk of HIV: a meta-analysis of randomized controlled trials. J Acquir Immune Defic Syndr. 2009;51(4):492–501.PubMedCentralPubMedCrossRef
9.
go back to reference Fishbein M, Jarvis B. Failure to find a behavioral surrogate for STD incidence–what does it really mean? Sex Transm Dis. 2000;27(8):452–5.PubMedCrossRef Fishbein M, Jarvis B. Failure to find a behavioral surrogate for STD incidence–what does it really mean? Sex Transm Dis. 2000;27(8):452–5.PubMedCrossRef
10.
go back to reference Peterman TA, Lin LS, Newman DR, Kamb ML, Bolan G, Zenilman J, et al. Does measured behavior reflect STD risk? An analysis of data from a randomized controlled behavioral intervention study. Project RESPECT Study Group. Sex Transm Dis. 2000;27(8):446–51.PubMedCrossRef Peterman TA, Lin LS, Newman DR, Kamb ML, Bolan G, Zenilman J, et al. Does measured behavior reflect STD risk? An analysis of data from a randomized controlled behavioral intervention study. Project RESPECT Study Group. Sex Transm Dis. 2000;27(8):446–51.PubMedCrossRef
11.
go back to reference Pequegnat W, Fishbein M, Celentano D, Ehrhardt A, Garnett G, Holtgrave D, et al. NIMH/APPC workgroup on behavioral and biological outcomes in HIV/STD prevention studies: a position statement. Sex Transm Dis. 2000;27(3):127–32.PubMedCrossRef Pequegnat W, Fishbein M, Celentano D, Ehrhardt A, Garnett G, Holtgrave D, et al. NIMH/APPC workgroup on behavioral and biological outcomes in HIV/STD prevention studies: a position statement. Sex Transm Dis. 2000;27(3):127–32.PubMedCrossRef
12.
go back to reference Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet. 1998;351(3):5–7.PubMedCrossRef Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet. 1998;351(3):5–7.PubMedCrossRef
13.
14.
go back to reference Scott-Sheldon LA, Huedo-Medina TB, Warren MR, Johnson BT, Carey MP. Efficacy of behavioral interventions to increase condom use and reduce sexually transmitted infections: a meta-analysis, 1991–2010. J Acquir Immune Defic Syndr. 2011;58(5):489–98.PubMedCrossRef Scott-Sheldon LA, Huedo-Medina TB, Warren MR, Johnson BT, Carey MP. Efficacy of behavioral interventions to increase condom use and reduce sexually transmitted infections: a meta-analysis, 1991–2010. J Acquir Immune Defic Syndr. 2011;58(5):489–98.PubMedCrossRef
15.
go back to reference Eaton LA, Huedo-Medina TB, Kalichman SC, Pellowski JA, Sagherian MJ, Warren M, et al. Meta-analysis of single-session behavioral interventions to prevent sexually transmitted infections: implications for bundling prevention packages. Am J Public Health. 2012;102(11):e34–44.PubMedCentralPubMedCrossRef Eaton LA, Huedo-Medina TB, Kalichman SC, Pellowski JA, Sagherian MJ, Warren M, et al. Meta-analysis of single-session behavioral interventions to prevent sexually transmitted infections: implications for bundling prevention packages. Am J Public Health. 2012;102(11):e34–44.PubMedCentralPubMedCrossRef
16.
go back to reference Padian NS, McCoy SI, Balkus JE, Wasserheit JN. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS. 2010;24(5):621–35.PubMedCentralPubMedCrossRef Padian NS, McCoy SI, Balkus JE, Wasserheit JN. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS. 2010;24(5):621–35.PubMedCentralPubMedCrossRef
17.
go back to reference Koblin B, Chesney M, Coates T. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet. 2004;364(9428):41–50.PubMedCrossRef Koblin B, Chesney M, Coates T. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet. 2004;364(9428):41–50.PubMedCrossRef
18.
go back to reference Chesney MA, Koblin BA, Barresi PJ, Husnik MJ, Celum CL, Colfax G, et al. An individually tailored intervention for HIV prevention: baseline data from the EXPLORE Study. Am J Public Health. 2003;93(6):933–8.PubMedCentralPubMedCrossRef Chesney MA, Koblin BA, Barresi PJ, Husnik MJ, Celum CL, Colfax G, et al. An individually tailored intervention for HIV prevention: baseline data from the EXPLORE Study. Am J Public Health. 2003;93(6):933–8.PubMedCentralPubMedCrossRef
19.
go back to reference Kamb M, Fishbein M, Douglas J, Rhodes F, Rogers J, Bolan G, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases. J Am Med Assoc. 1998;280(13):1161–7.CrossRef Kamb M, Fishbein M, Douglas J, Rhodes F, Rogers J, Bolan G, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases. J Am Med Assoc. 1998;280(13):1161–7.CrossRef
20.
go back to reference Investigators E. HIVNET 015 executive summary. (Protocol document available from the study team, 2004 in press). Investigators E. HIVNET 015 executive summary. (Protocol document available from the study team, 2004 in press).
21.
go back to reference Jepson RG, Harris FM, Platt S, Tannahill C. The effectiveness of interventions to change six health behaviours: a review of reviews. BMC public health. 2010;10:538.PubMedCentralPubMedCrossRef Jepson RG, Harris FM, Platt S, Tannahill C. The effectiveness of interventions to change six health behaviours: a review of reviews. BMC public health. 2010;10:538.PubMedCentralPubMedCrossRef
22.
23.
go back to reference Lau JT, Lau M, Cheung A, Tsui HY. A randomized controlled study to evaluate the efficacy of an Internet-based intervention in reducing HIV risk behaviors among men who have sex with men in Hong Kong. AIDS Care. 2008;20(7):820–8.PubMedCrossRef Lau JT, Lau M, Cheung A, Tsui HY. A randomized controlled study to evaluate the efficacy of an Internet-based intervention in reducing HIV risk behaviors among men who have sex with men in Hong Kong. AIDS Care. 2008;20(7):820–8.PubMedCrossRef
24.
go back to reference Lama JR, Lucchetti A, Suarez L, Laguna-Torres VA, Guanira JV, Pun M, et al. Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru. J Infect Dis. 2006;194(10):1459–66.PubMedCrossRef Lama JR, Lucchetti A, Suarez L, Laguna-Torres VA, Guanira JV, Pun M, et al. Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru. J Infect Dis. 2006;194(10):1459–66.PubMedCrossRef
25.
go back to reference Clark T, Marquez C, Hare CB, John MD, Klausner JD. Methamphetamine use, transmission risk behavior and internet use among HIV-infected patients in medical care, San Francisco, 2008. AIDS Behav. 2012;16(2):396–403.PubMedCentralPubMedCrossRef Clark T, Marquez C, Hare CB, John MD, Klausner JD. Methamphetamine use, transmission risk behavior and internet use among HIV-infected patients in medical care, San Francisco, 2008. AIDS Behav. 2012;16(2):396–403.PubMedCentralPubMedCrossRef
26.
go back to reference Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1–17.PubMed Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1–17.PubMed
27.
go back to reference Policy TWHOoNA. National HIV/AIDS strategy for the United States. Washington DC: US Government; 2010. Policy TWHOoNA. National HIV/AIDS strategy for the United States. Washington DC: US Government; 2010.
28.
go back to reference Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009;361(23):2209–20.PubMedCrossRef Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009;361(23):2209–20.PubMedCrossRef
29.
go back to reference Stall R, Duran L, Wisniewski SR, Friedman MS, Marshal MP, McFarland W, et al. Running in place: implications of HIV incidence estimates among urban men who have sex with men in the United States and other industrialized countries. AIDS Behav. 2009;13(4):615–29.PubMedCentralPubMedCrossRef Stall R, Duran L, Wisniewski SR, Friedman MS, Marshal MP, McFarland W, et al. Running in place: implications of HIV incidence estimates among urban men who have sex with men in the United States and other industrialized countries. AIDS Behav. 2009;13(4):615–29.PubMedCentralPubMedCrossRef
30.
go back to reference Kalichman SC. HIV treatments as prevention (TasP) : primer for behavior-based implementation. New York: Springer; 2013. p. 132.CrossRef Kalichman SC. HIV treatments as prevention (TasP) : primer for behavior-based implementation. New York: Springer; 2013. p. 132.CrossRef
31.
go back to reference Safren SA, Wingood G, Altice FL. Strategies for primary HIV prevention that target behavioral change. Clin Infect Dis. 2007;45(4):S300–7.PubMedCrossRef Safren SA, Wingood G, Altice FL. Strategies for primary HIV prevention that target behavioral change. Clin Infect Dis. 2007;45(4):S300–7.PubMedCrossRef
32.
go back to reference Eaton LA, Kalichman SC, Kenny DA, Harel O. A reanalysis of a behavioral intervention to prevent incident HIV infections: Including indirect effects in modeling outcomes of Project EXPLORE. AIDS Care. 2012;25(7):805–11.PubMedCrossRef Eaton LA, Kalichman SC, Kenny DA, Harel O. A reanalysis of a behavioral intervention to prevent incident HIV infections: Including indirect effects in modeling outcomes of Project EXPLORE. AIDS Care. 2012;25(7):805–11.PubMedCrossRef
33.
go back to reference Auerbach JD, Hayes RJ, Kandathil SM. Overview of effective and promising interventions to prevent HIV infection. World Health Organ Tech Rep Ser. 2006;938:43–78 (discussion 317–41).PubMed Auerbach JD, Hayes RJ, Kandathil SM. Overview of effective and promising interventions to prevent HIV infection. World Health Organ Tech Rep Ser. 2006;938:43–78 (discussion 317–41).PubMed
34.
go back to reference Bedoya CA, Mimiaga MJ, Beauchamp G, Donnell D, Mayer KH, Safren SA. Predictors of HIV transmission risk behavior and seroconversion among Latino men who have sex with men in Project EXPLORE. AIDS Behav. 2012;16(3):608–17.PubMedCentralPubMedCrossRef Bedoya CA, Mimiaga MJ, Beauchamp G, Donnell D, Mayer KH, Safren SA. Predictors of HIV transmission risk behavior and seroconversion among Latino men who have sex with men in Project EXPLORE. AIDS Behav. 2012;16(3):608–17.PubMedCentralPubMedCrossRef
35.
go back to reference Berg RC, Ross MW, Tikkanen R. The effectiveness of MI4MSM: how useful is motivational interviewing as an HIV risk prevention program for men who have sex with men? A systematic review. AIDS Educ Prev. 2011;23(6):533–49.PubMedCrossRef Berg RC, Ross MW, Tikkanen R. The effectiveness of MI4MSM: how useful is motivational interviewing as an HIV risk prevention program for men who have sex with men? A systematic review. AIDS Educ Prev. 2011;23(6):533–49.PubMedCrossRef
36.
go back to reference Brown EL, Wald A, Hughes JP, Morrow RA, Krantz E, Mayer K, et al. High-risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. Am J Epidemiol. 2006;164(8):733–41.PubMedCrossRef Brown EL, Wald A, Hughes JP, Morrow RA, Krantz E, Mayer K, et al. High-risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. Am J Epidemiol. 2006;164(8):733–41.PubMedCrossRef
37.
go back to reference Golden MR, Manhart LE. Innovative approaches to the prevention and control of bacterial sexually transmitted infections. Infect Dis Clin North Am. 2005;19(2):513–40.PubMedCrossRef Golden MR, Manhart LE. Innovative approaches to the prevention and control of bacterial sexually transmitted infections. Infect Dis Clin North Am. 2005;19(2):513–40.PubMedCrossRef
38.
go back to reference Grant RM, Buchbinder S, Cates W Jr, Clarke E, Coates T, Cohen MS, et al. AIDS. Promote HIV chemoprophylaxis research, don’t prevent it. Science. 2005;309(5744):2170–1.PubMedCrossRef Grant RM, Buchbinder S, Cates W Jr, Clarke E, Coates T, Cohen MS, et al. AIDS. Promote HIV chemoprophylaxis research, don’t prevent it. Science. 2005;309(5744):2170–1.PubMedCrossRef
40.
go back to reference Herbst JH, Beeker C, Mathew A, McNally T, Passin WF, Kay LS, et al. The effectiveness of individual-, group-, and community-level HIV behavioral risk-reduction interventions for adult men who have sex with men: a systematic review. Am J Prev Med. 2007;32(4 Suppl):S38–67.PubMedCrossRef Herbst JH, Beeker C, Mathew A, McNally T, Passin WF, Kay LS, et al. The effectiveness of individual-, group-, and community-level HIV behavioral risk-reduction interventions for adult men who have sex with men: a systematic review. Am J Prev Med. 2007;32(4 Suppl):S38–67.PubMedCrossRef
41.
go back to reference Lyles CM, Kay LS, Crepaz N, Herbst JH, Passin WF, Kim AS, et al. Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high-risk, 2000–2004. Am J Public Health. 2007;97(1):133–43.PubMedCentralPubMedCrossRef Lyles CM, Kay LS, Crepaz N, Herbst JH, Passin WF, Kim AS, et al. Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high-risk, 2000–2004. Am J Public Health. 2007;97(1):133–43.PubMedCentralPubMedCrossRef
42.
go back to reference Mansergh G, Koblin BA, McKirnan DJ, Hudson SM, Flores SA, Wiegand RE, et al. An intervention to reduce HIV risk behavior of substance-using men who have sex with men: a two-group randomized trial with a nonrandomized third group. PLoS Med. 2010;7(8):e1000329.PubMedCentralPubMedCrossRef Mansergh G, Koblin BA, McKirnan DJ, Hudson SM, Flores SA, Wiegand RE, et al. An intervention to reduce HIV risk behavior of substance-using men who have sex with men: a two-group randomized trial with a nonrandomized third group. PLoS Med. 2010;7(8):e1000329.PubMedCentralPubMedCrossRef
43.
go back to reference Mimiaga MJ, Noonan E, Donnell D, Safren SA, Koenen KC, Gortmaker S, et al. Childhood sexual abuse is highly associated with HIV risk-taking behavior and infection among MSM in the EXPLORE Study. J Acquir Immune Defic Syndr. 2009;51(3):340–8.PubMedCentralPubMedCrossRef Mimiaga MJ, Noonan E, Donnell D, Safren SA, Koenen KC, Gortmaker S, et al. Childhood sexual abuse is highly associated with HIV risk-taking behavior and infection among MSM in the EXPLORE Study. J Acquir Immune Defic Syndr. 2009;51(3):340–8.PubMedCentralPubMedCrossRef
44.
go back to reference Miranda AE, Nasser SO, Simon M, Guerra PB. Sant’ Anna PM. Risk factors and prevalence of HIV infection in people seeking health care in an STI clinic in Brazil. AIDS Care. 2007;19(1):75–8.PubMedCrossRef Miranda AE, Nasser SO, Simon M, Guerra PB. Sant’ Anna PM. Risk factors and prevalence of HIV infection in people seeking health care in an STI clinic in Brazil. AIDS Care. 2007;19(1):75–8.PubMedCrossRef
45.
go back to reference Morgenstern J, Bux DA Jr, Parsons J, Hagman BT, Wainberg M, Irwin T. Randomized trial to reduce club drug use and HIV risk behaviors among men who have sex with men. J Consult Clin Psychol. 2009;77(4):645–56.PubMedCentralPubMedCrossRef Morgenstern J, Bux DA Jr, Parsons J, Hagman BT, Wainberg M, Irwin T. Randomized trial to reduce club drug use and HIV risk behaviors among men who have sex with men. J Consult Clin Psychol. 2009;77(4):645–56.PubMedCentralPubMedCrossRef
46.
go back to reference Morin SF, Shade SB, Steward WT, Carrico AW, Remien RH, Rotheram-Borus MJ, et al. A behavioral intervention reduces HIV transmission risk by promoting sustained serosorting practices among HIV-infected men who have sex with men. J Acquir Immune Defic Syndr. 2008;49(5):544–51.PubMedCentralPubMedCrossRef Morin SF, Shade SB, Steward WT, Carrico AW, Remien RH, Rotheram-Borus MJ, et al. A behavioral intervention reduces HIV transmission risk by promoting sustained serosorting practices among HIV-infected men who have sex with men. J Acquir Immune Defic Syndr. 2008;49(5):544–51.PubMedCentralPubMedCrossRef
47.
go back to reference Pilcher CD, Christopoulos KA, Golden M. Public health rationale for rapid nucleic acid or p24 antigen tests for HIV. J Infect Dis. 2010;201(Suppl 1):S7–15.PubMedCrossRef Pilcher CD, Christopoulos KA, Golden M. Public health rationale for rapid nucleic acid or p24 antigen tests for HIV. J Infect Dis. 2010;201(Suppl 1):S7–15.PubMedCrossRef
48.
49.
go back to reference Rotheram-Borus MJ, Leibowitz AA, Etzel MA. Routine, rapid HIV testing. AIDS Educ Prev. 2006;18(3):273–80.PubMedCrossRef Rotheram-Borus MJ, Leibowitz AA, Etzel MA. Routine, rapid HIV testing. AIDS Educ Prev. 2006;18(3):273–80.PubMedCrossRef
50.
go back to reference Rotheram-Borus MJ, Wu Z, Li L, Detels R, Liang LJ, Group NCHSPT. Spontaneous remission of sexually transmitted diseases must be considered in randomised controlled trials. Sex Transm Infect. 2011;87(4):305.PubMedCentralPubMedCrossRef Rotheram-Borus MJ, Wu Z, Li L, Detels R, Liang LJ, Group NCHSPT. Spontaneous remission of sexually transmitted diseases must be considered in randomised controlled trials. Sex Transm Infect. 2011;87(4):305.PubMedCentralPubMedCrossRef
51.
go back to reference Sanchez J, Lama JR, Peinado J, Paredes A, Lucchetti A, Russell K, et al. High HIV and ulcerative sexually transmitted infection incidence estimates among men who have sex with men in Peru: awaiting for an effective preventive intervention. J Acquir Immune Defic Syndr. 2009;51(Suppl 1):S47–51.PubMedCentralPubMedCrossRef Sanchez J, Lama JR, Peinado J, Paredes A, Lucchetti A, Russell K, et al. High HIV and ulcerative sexually transmitted infection incidence estimates among men who have sex with men in Peru: awaiting for an effective preventive intervention. J Acquir Immune Defic Syndr. 2009;51(Suppl 1):S47–51.PubMedCentralPubMedCrossRef
52.
go back to reference Schneider JA, Dude A, Dinaker M, Kumar V, Laumann EO, Holloway-Beth A, et al. General hygiene, sexual risk behaviour and HIV prevalence in truck drivers from Andhra Pradesh, South India: implications for prevention interventions. Int J STD AIDS. 2009;20(1):39–45.PubMedCrossRef Schneider JA, Dude A, Dinaker M, Kumar V, Laumann EO, Holloway-Beth A, et al. General hygiene, sexual risk behaviour and HIV prevalence in truck drivers from Andhra Pradesh, South India: implications for prevention interventions. Int J STD AIDS. 2009;20(1):39–45.PubMedCrossRef
53.
go back to reference Smith DK, Pals SL, Herbst JH, Shinde S, Carey JW. Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2012;60(4):421–7.PubMedCrossRef Smith DK, Pals SL, Herbst JH, Shinde S, Carey JW. Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2012;60(4):421–7.PubMedCrossRef
54.
go back to reference Sullivan PS, Carballo-Diéguez A, Coates T, Goodreau SM, McGowan I, Sanders EJ, et al. Successes and challenges of HIV prevention in men who have sex with men. Lancet. 2012;380(9839):388–99.PubMedCentralPubMedCrossRef Sullivan PS, Carballo-Diéguez A, Coates T, Goodreau SM, McGowan I, Sanders EJ, et al. Successes and challenges of HIV prevention in men who have sex with men. Lancet. 2012;380(9839):388–99.PubMedCentralPubMedCrossRef
55.
go back to reference Zenilman JM. Behavioral interventions–rationale, measurement, and effectiveness. Infect Dis Clin North Am. 2005;19(2):541–62.PubMedCrossRef Zenilman JM. Behavioral interventions–rationale, measurement, and effectiveness. Infect Dis Clin North Am. 2005;19(2):541–62.PubMedCrossRef
56.
go back to reference Chen P. Measures needed to strengthen strategic HIV/AIDS prevention programmes in China. Asia Pac J Public Health. 2007;19(1):3–7.PubMedCrossRef Chen P. Measures needed to strengthen strategic HIV/AIDS prevention programmes in China. Asia Pac J Public Health. 2007;19(1):3–7.PubMedCrossRef
57.
go back to reference Donnell D, Hughes JP, Fleming TR. Challenges in the design of HIV prevention trials in the United States. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S136–40.PubMedCentralPubMedCrossRef Donnell D, Hughes JP, Fleming TR. Challenges in the design of HIV prevention trials in the United States. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S136–40.PubMedCentralPubMedCrossRef
59.
go back to reference Mimiaga MJ, Safren SA, Benet DJ, Manseau MW, DeSousa N, Mayer KH. MSM in HIV prevention trials are sexual partners with each other: An ancillary study to the EXPLORE intervention. AIDS Behav. 2006;10(1):27–34.PubMedCrossRef Mimiaga MJ, Safren SA, Benet DJ, Manseau MW, DeSousa N, Mayer KH. MSM in HIV prevention trials are sexual partners with each other: An ancillary study to the EXPLORE intervention. AIDS Behav. 2006;10(1):27–34.PubMedCrossRef
60.
go back to reference Metzger DS, Woody G, O’Brien CP. Drug treatment as HIV prevention: a research update. J Acquir Immune Defic Syndr. 2010;55(1):32–6.CrossRef Metzger DS, Woody G, O’Brien CP. Drug treatment as HIV prevention: a research update. J Acquir Immune Defic Syndr. 2010;55(1):32–6.CrossRef
61.
go back to reference Rotheram-Borus MJ, Desmond K, Comulada WS, Arnold EM, Johnson M. Healthy Living Trial G. Reducing risky sexual behavior and substance use among currently and formerly homeless adults living with HIV. Am J Public Health. 2009;99(6):1100–7.PubMedCentralPubMedCrossRef Rotheram-Borus MJ, Desmond K, Comulada WS, Arnold EM, Johnson M. Healthy Living Trial G. Reducing risky sexual behavior and substance use among currently and formerly homeless adults living with HIV. Am J Public Health. 2009;99(6):1100–7.PubMedCentralPubMedCrossRef
62.
Metadata
Title
Setting the Bar High or Setting Up to Fail? Interpretations and Implications of The EXPLORE Study (HPTN 015)
Authors
Seth C. Kalichman
Larissa Zohren
Lisa A. Eaton
Publication date
01-04-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0603-0

Other articles of this Issue 4/2014

AIDS and Behavior 4/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.